263 related articles for article (PubMed ID: 19863241)
1. Ixiaro: a new vaccine against Japanese encephalitis.
Jelinek T
Expert Rev Vaccines; 2009 Nov; 8(11):1501-11. PubMed ID: 19863241
[TBL] [Abstract][Full Text] [Related]
2. IC51 Japanese encephalitis vaccine.
Kollaritsch H; Paulke-Korinek M; Dubischar-Kastner K
Expert Opin Biol Ther; 2009 Jul; 9(7):921-31. PubMed ID: 19527110
[TBL] [Abstract][Full Text] [Related]
3. Japanese encephalitis: update on vaccines and vaccine recommendations.
Wilder-Smith A; Halstead SB
Curr Opin Infect Dis; 2010 Oct; 23(5):426-31. PubMed ID: 20581670
[TBL] [Abstract][Full Text] [Related]
4. IXIARO updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis.
Jelinek T
Expert Rev Vaccines; 2013 Aug; 12(8):859-69. PubMed ID: 23984958
[TBL] [Abstract][Full Text] [Related]
5. New Japanese encephalitis vaccines: alternatives to production in mouse brain.
Halstead SB; Thomas SJ
Expert Rev Vaccines; 2011 Mar; 10(3):355-64. PubMed ID: 21434803
[TBL] [Abstract][Full Text] [Related]
6. Japanese encephalitis: new options for active immunization.
Halstead SB; Thomas SJ
Clin Infect Dis; 2010 Apr; 50(8):1155-64. PubMed ID: 20218889
[TBL] [Abstract][Full Text] [Related]
7. Product review on the JE vaccine IXIARO.
Firbas C; Jilma B
Hum Vaccin Immunother; 2015; 11(2):411-20. PubMed ID: 25621812
[TBL] [Abstract][Full Text] [Related]
8. Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO(®).
Schuller E; Klingler A; Dubischar-Kastner K; Dewasthaly S; Müller Z
Vaccine; 2011 Nov; 29(47):8669-76. PubMed ID: 21907747
[TBL] [Abstract][Full Text] [Related]
9. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
[TBL] [Abstract][Full Text] [Related]
10. Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine.
Tauber E; Kollaritsch H; von Sonnenburg F; Lademann M; Jilma B; Firbas C; Jelinek T; Beckett C; Knobloch J; McBride WJ; Schuller E; Kaltenböck A; Sun W; Lyons A
J Infect Dis; 2008 Aug; 198(4):493-9. PubMed ID: 18588481
[TBL] [Abstract][Full Text] [Related]
11. Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up.
Dubischar-Kastner K; Kaltenboeck A; Klingler A; Jilma B; Schuller E
Vaccine; 2010 Sep; 28(39):6463-9. PubMed ID: 20673824
[TBL] [Abstract][Full Text] [Related]
12. The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis.
Erra EO; Kantele A
Expert Rev Vaccines; 2015; 14(9):1167-79. PubMed ID: 26162529
[TBL] [Abstract][Full Text] [Related]
13. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Fischer M; Lindsey N; Staples JE; Hills S;
MMWR Recomm Rep; 2010 Mar; 59(RR-1):1-27. PubMed ID: 20224546
[TBL] [Abstract][Full Text] [Related]
14. Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO
Amicizia D; Zangrillo F; Lai PL; Iovine M; Panatto D
J Prev Med Hyg; 2018 Mar; 59(1):E99-E107. PubMed ID: 29938245
[TBL] [Abstract][Full Text] [Related]
15. IC-51, an injectable vaccine for the prevention of Japanese encephalitis virus infection.
Jones T
Curr Opin Mol Ther; 2009 Feb; 11(1):90-6. PubMed ID: 19169964
[TBL] [Abstract][Full Text] [Related]
16. A new Japanese encephalitis vaccine (Ixiaro).
Med Lett Drugs Ther; 2009 Aug; 51(1319):66-7. PubMed ID: 19696707
[No Abstract] [Full Text] [Related]
17. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
Appaiahgari MB; Vrati S
Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774
[TBL] [Abstract][Full Text] [Related]
18. Superior immunogenicity of a freeze-dried, cell culture-derived Japanese encephalitis vaccine (inactivated).
Kikukawa A; Gomi Y; Akechi M; Onishi T; Manabe S; Namazue J; Fuke I; Ishikawa T; Okuno Y; Ueda S
Vaccine; 2012 Mar; 30(13):2329-35. PubMed ID: 22306856
[TBL] [Abstract][Full Text] [Related]
19. Japanese encephalitis vaccine in travelers.
Jelinek T
Expert Rev Vaccines; 2008 Jul; 7(5):689-93. PubMed ID: 18564023
[TBL] [Abstract][Full Text] [Related]
20. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
